Media Advisory - BMO Capital Markets to Host Annual "Focus on Healthcare" Investor Conference



    NEW YORK, Nov. 29 /CNW/ - BMO Capital Markets, the investment and
corporate banking arm of BMO Financial Group (NYSE, TSX: BMO), will host its
annual Focus on Healthcare Conference on December 4th and 5th at the
Millennium Broadway Hotel in New York City.
    The event brings together a number of senior management from leading and
emerging companies for an in-depth review of the healthcare industry's current
challenges and future opportunities:
    Hosted by members of the BMO Capital Markets Healthcare Equity Research
Team including Erik Chiprich, Robert Hazlett, Dave Shove, Joanne Wuensch and
Jason Zhang, this two-day event features a unique mix of presentations by
public and private companies focused on the following sectors:

    
    -   Biotechnology
    -   Healthcare Facilities
    -   Medical Technology & Devices
    -   Pharmaceuticals & Specialty Pharmaceuticals
    

    BMO Capital Markets is also proud to welcome keynote speaker, former U.S.
Senate Majority Leader Bill Frist, M.D. As a leading American physician,
businessman and former U.S. Senator, Dr. Frist has emerged as one of the
leading voices on health issues in America today.
    The conference will be webcast live and archived on the BMO Capital
Markets website: http://www.bmocm.com/conferences/2007healthcare.
    An up-to-the-minute agenda(*) with presentation times for the entire
conference is also available on the website.
    Media interested in attending the event and/or scheduling an interview
are asked to call (416) 867-3996.

    A total of 89 companies are scheduled to participate. They include:

    AEterna Zentaris, Inc. (AEZS)
    Akela Pharma Inc. (AKL.TO)
    Allos Therapeutics (ALTH)
    Alphatec Spine, Inc. (ATEC)
    Amedisys, Inc. (AMED)
    American CareSource Holdings (XSI)
    Antares Pharma, Inc. (AIS)
    Arqule, Inc. (ARQL)
    ArthroCare Corporation (ARTC)
    Assisted Living Concepts (ALC)
    Atricure (ATRC)
    Bio-Imaging Technologies, Inc. (BITI)
    Bionovo (BNVI.OB)
    BioSphere Medical (BSMD)
    Boston Scientific Corp. (BSX)
    Capital Senior Living (CSU)
    Cardiva Medical
    Celgene Corp. (CELG)
    CollaGenex Pharmaceuticals, Inc. (CGPI)
    Continucare Corp. (CNU)
    Cortex Pharmaceuticals, Inc. (COR)
    CryoCath Technologies (CYT)
    Elite Pharmaceuticals, Inc. (ELI)
    Enzon Pharmaceuticals (ENZN)
    EpiCept Corp. (EPCT)
    ESTECH
    Extendicare Real Estate Investment Trust (EXE.UN)
    eyeonics, inc.
    Greatbatch, inc. (GB)
    Idera Pharmaceuticals (IDP)
    Immtech Pharmaceuticlas, Inc. (IMM)
    Immunogen, Inc. (IMGN)
    Innovative Spinal Technologies, Inc.
    Integra Lifesciences Corp (IART)
    King Pharmaceuticals, Inc. (KG)
    LCA-Vision, Inc. (LCAV)
    MacroGenics
    MedCath Corp. (MDTH)
    Medical Facilities Corp. (DR.UN)
    Medicalis
    MethylGene, Inc. (MYG.TO)
    MGI Pharma (MOGN)
    Millennium Pharmaceuticals (MLNM)
    MIV Therapeutics (MIVT)
    MX USA
    Nabi Biopharmaceuticals, Inc. (NABI)
    Napo Pharmaceuticals, Inc.
    Nastech Pharmaceutical Company, Inc. (NSTK)
    Nektar Therapeutics (NKTR)
    NorthStar Healthcare Inc. (NHC)
    Novadaq Technologies (NDQ)
    NovaMed, Inc. (NOVA)
    Novavax, Inc. (NVAX)
    Numoda Corp.
    Oscient Pharmaceuticals (OSCI)
    Paratek Pharmaceuticals
    Penwest (PPCO)
    Pharmacopeia (PCOP)
    Possis Medical, Inc. (POSS)
    Pozen Inc. (POZN)
    Progenics Pharmaceuticals, Inc. (PGNX)
    Protein Sciences Corp.
    Questcor Pharmaceuticals, Inc. (QSC)
    Regeneron Pharmaceuticals, Inc. (REGN)
    ReNeuron Group plc (RENE.L)
    Repligen Corporation (RGEN)
    ResMed (RMD)
    Respironics, Inc. (RESP)
    Response Biomedical Corporation (RBM)
    Rib-X Pharmaceuticals
    Salix Pharmaceuticals (SLXP)
    Sangamo BioSciences, Inc. (SGMO)
    SCYNEXIS
    SenoRx (SENO)
    Sepracor Inc. (SEPR)
    STAAR Surgical (STAA)
    SuperGen (SUPG)
    The Cooper Companies Inc. (COO)
    The Parker Group
    The Schumacher Group
    Theratechnologies, Inc. (TH.TO)
    TissueLink
    TLCVision Corp. (TLCV)
    Topigen Pharmaceuticals
    U.S. Physical Therapy, Inc. (USPH)
    Universal Health Services, Inc. (UHS)
    Vitae Pharmaceuticals, Inc.
    Xtent, Inc. (XTNT)
    Zimmer Holdings Inc. (ZMH)

    (*) Agenda and participant list subject to change.

    About BMO Capital Markets

    BMO Capital Markets is a leading full-service North American financial
services provider, with over 2,000 employees operating in 14 North American
offices and 26 worldwide, offering corporate, institutional and government
clients access to a complete range of investment and corporate banking
products and services. BMO Capital Markets is a member of BMO Financial Group
(NYSE, TSX: BMO), one of the largest diversified financial services providers
in North America with more than CAN$366.5 billion in total assets and more
than 35,000 employees as at October 31, 2007. For more information, visit
www.bmocm.com.





For further information:

For further information: Media Relations Contacts: Kim Hanson, Toronto,
kim.hanson@bmo.com, (416) 867-3996; Kevin Windorf, New York,
kevin.windorf@bmo.com, (212) 885-4111; Chris Nardella, Chicago,
chris.nardella@bmo.com, (312) 461-6625

Organization Profile

BMO CAPITAL MARKETS

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890